Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,200
Closed -$393K 115
2025
Q4
$393K Buy
1,200
+500
+71% +$159K 0.25% 82
2025
Q3
$198K Buy
+700
New +$203K 0.1% 119
2025
Q2
Sell
-2,700
Closed -$841K 59
2025
Q1
$841K Sell
2,700
-900
-25% -$266K 0.24% 89
2024
Q4
$938K Buy
3,600
+1,600
+80% +$475K 0.45% 60
2024
Q3
$644K Sell
2,000
-1,500
-43% -$491K 0.22% 66
2024
Q2
$1.09M Buy
3,500
+500
+17% +$147K 0.69% 38
2024
Q1
$853K Sell
3,000
-2,600
-46% -$761K 0.38% 61
2023
Q4
$1.61M Buy
5,600
+2,300
+70% +$627K 0.94% 31
2023
Q3
$887K Buy
+3,300
New +$824K 0.51% 51

Other funds holding AMGN

XY Capital's AMGN Position: Q2 2025 in Review

XY Capital sold out of Amgen (AMGN) in Q2 2025, closing a stake of 581 shares — an estimated $181K sold.

XY Capital first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $221K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • XY Capital reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • XY Capital sold 581 Amgen shares in Q2 2025, an estimated $181K.
  • XY Capital first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • XY Capital's Amgen position peaked at $221K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.